Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.
Horstink, M W
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. [electronic resource] - Journal of neurology, neurosurgery, and psychiatry Mar 1990 - 224-6 p. digital
Publication Type: Comparative Study; Journal Article
0022-3050
10.1136/jnnp.53.3.224 doi
Aged
Antiparkinson Agents--administration & dosage
Benserazide--administration & dosage
Carbidopa--administration & dosage
Carboxy-Lyases--antagonists & inhibitors
Dose-Response Relationship, Drug
Drug Combinations--administration & dosage
Dyskinesia, Drug-Induced--diagnosis
Humans
Hydrazines--adverse effects
Levodopa--administration & dosage
Middle Aged
Motor Skills--drug effects
Neurologic Examination
Parkinson Disease--drug therapy
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. [electronic resource] - Journal of neurology, neurosurgery, and psychiatry Mar 1990 - 224-6 p. digital
Publication Type: Comparative Study; Journal Article
0022-3050
10.1136/jnnp.53.3.224 doi
Aged
Antiparkinson Agents--administration & dosage
Benserazide--administration & dosage
Carbidopa--administration & dosage
Carboxy-Lyases--antagonists & inhibitors
Dose-Response Relationship, Drug
Drug Combinations--administration & dosage
Dyskinesia, Drug-Induced--diagnosis
Humans
Hydrazines--adverse effects
Levodopa--administration & dosage
Middle Aged
Motor Skills--drug effects
Neurologic Examination
Parkinson Disease--drug therapy